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called “Brain Attack: A Body of Knowledge, 
A Coalition of Support.” In 2000, the Brain 
Attack Coalition (BAC) published their ini-
tial recommendations for the establishment 
of primary stroke centers (PSC) to improve 
the care of patients with stroke (Alberts et al., 
2000). These PSCs would have designated 
acute stroke teams, stroke units, written 
care protocols, and an integrated emergency 
response system along with quick access to 
ancillary investigations including laboratory 
studies and computerized tomography (CT; 
Alberts et al., 2000). There was also a pro-
posal for establishment of two levels of care 
for acute stroke patients based on the trauma 
level system of care (Schneck, 1998). The PSC 
would stabilize and treats acute stroke patient 
and provide them with initial care including 
intravenous thrombolytic therapy utilizing 
tPA, as well as other acute therapies such as 
stabilization of vital functions, provision of 
neuroimaging procedures, and management 
of intracranial pressure (Alberts et al., 2000). 
However, patients with more difficult to treat 
or more complex strokes with severe deficits 
and multi-organ involvement would require 
more resources and a higher intensity of care 
than is offered by the PSC. In these situations, 
PSC could transfer patients to a comprehen-
sive stroke center (CSC; Alberts et al., 2005). 
The CSC would treat acute stroke patient at 
all needed levels of care and offer specialized 
care and interventions for highly technical 
procedures such as intra-arterial thromboly-
sis, neurosurgical, and neurointensive care 
requiring specialized infrastructure and per-
sonnel (Alberts et al., 2005).
After an extensive review of published 
literature concerning the establishment 
of medical centers, with a focus on stroke 
and trauma centers, the BAC identified 
11 major elements to be incorporated in 
a PSC, which are highlighted in Table 1 
(Alberts et al., 2000). The BAC endorsed 
formal certification programs such as 
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The American Heart Association estimates 
that, as of calendar year 2010, approximately 
795,000 people in the USA will have expe-
rienced a new or recurrent stroke, out of 
which 610,000 were new attacks (Heart 
Disease and Stroke Statistics – 2010 Update, 
2010). Stroke is the third leading cause of 
death in United States and a major cause 
of disability. There are almost three million 
survivors of stroke, most of whom are disa-
bled with a societal cost of approximately 
$30 billion (US dollars; Heart Disease and 
Stroke Statistics – 2010 Update, 2010). 
Over the last two decades, there have been 
major advances have been made in the early 
diagnosis of stroke and timely treatment. In 
1996, the US Food and Drug Administration 
(USFDA) approved intravenous tissue 
plasminogen activator (IV tPA) for the 
treatment of acute ischemic stroke within 
3 h of onset of symptoms (The National 
Institute of neurological Disorders and 
Stroke rt-PA Stroke Study Group, 1995). 
Despite the approval, only 1.8–4.1% of 
patients with acute ischemic stroke received 
IV tPA (Katzan et al., 2000). The failure to 
administer tPA in a timely fashion was evi-
dent from a paper, in calendar year 2000, 
showing that only 34% of academic hospi-
tals had defined stroke protocols and only 
18% had rapid identification methods for 
patients presenting with acute stroke symp-
toms (Johnson et al., 2001). A subsequent 
assessment of statewide acute stroke care in 
Illinois demonstrated that although 93.2% 
of residents in Illinois lived in a county 
with at least one acute care facility with tPA 
treatment protocol, there were many acute 
care receiving facilities outside of Greater 
Chicago Metropolitan Area which did not 
have a neurologist or a neurosurgeon avail-
able (Ruland et al., 2002).
In response, a group of medical organiza-
tions joined forces in an effort to improve 
this situation. The result was a project 
the Joint Commission Disease-Specific 
Certification process. By, January 2006, 
there were 174 PSCs certified by the 
Joint Commission on Accreditation 
of Healthcare Organizations (Joint 
Commission) and by October 2009 there 
were over 600 certified centers1. The Joint 
Commission and National Quality Forum 
endorsed 10 performance measures listed 
in Table 2, for programs seeking certifica-
tion as stroke centers. In 2010, the Joint 
commission eliminated the requirement 
for documentation of dysphagia screen-
ing while making the smoking cessation 
requirement universal. The ostensible 
reason for eliminating dysphagia screen-
ing was because of a lack of consensus on 
screening methods for dysphagia (see text 
footnote 1). US Centers for Medicare and 
Medicaid Services (CMS) is adopting these 
eight measures and considering whether 
to require them for future reporting pos-
sibly starting in 2012 in all hospitals that 
care for stroke2. In addition, starting 
in 2010 hospitals submitting Medicare 
claims must inform CMS whether they 
participate in a stroke care registry (see 
text footnote 2).
While the PSC requirements have been 
well-defined, there are as yet no formal net-
works of care based on the CSC concept. 
The BAC suggested the following elements 
be present for CSCs (Alberts et al., 2005):
1. Health care personnel with specific 
expertise in a number of disciplines, 
including neurosurgery and vascular 
neurology (but not neurointensivists).
2. Advanced neuroimaging capabilities 
such as MRI and various types of cere-
bral angiography.
1http://www.jointcommission.org/AboutUs/Fact_
Sheets/psc_certification.htm
2http://newsroom.heart.org/pr/aha/805.aspx
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entire follow-up of up to 9 years and their 
median survival was increased by 1 year 
(Meretoja et al., 2010).
The impact of establishing designated 
stroke centers has been often assessed by 
the use of thrombolytic therapy. In the 
NINDS suburban hospital stroke center 
experience in Bethesda, the rates if tPA 
administration at a community hospital 
before and after stroke center designation 
were assessed (Lattimore et al., 2003). Prior 
to the designation, the hospital lacked an 
acute stroke response team, 24 months 
after creation of an acute stroke team there 
was a sevenfold increase in tPA administra-
tion (1.5–10.5%). In addition, there was a 
decrease in the time from patient arrival 
at hospital to paging of the stroke team, 
time of stroke team page to team arrival, 
and time to screening brain scan over the 
24-month period (Lattimore et al., 2003). 
Wojner-Alexandrov et al. (2005), reported 
similar increases in use of tPA after BAC 
and American Stroke Association (ASA) 
guidelines were implemented over 1 year 
in two Houston Texas hospitals which had 
specialized stroke programs. Interestingly, 
these pre-existing stroke centers had sig-
nificantly lower emergency department 
arrival to CT interpretation times when 
compared to those of newly established 
stroke centers (Wojner-Alexandrov et al., 
2005).
Although the increased use of tPA has 
been associated with stroke center designa-
tion in both primary and comprehensive 
facilities, Douglas et al. (2005) reported 
that of the 11 elements recommended by 
BAC, only seven were related to increased 
tPA use. The study concluded that variables 
associated with higher tPA use were related 
to reducing delays in treatment, including 
emergency medical services, organized 
emergency departments, rapid neuroimag-
ing, and an acute stroke team. Also, continu-
ing medical education was found to increase 
tPA administration, by probably decreas-
ing the delay to treatment. Interestingly, 
the study was unable to demonstrate that 
any of the 11 elements were significantly 
related to decreased inpatient mortality 
or increased frequency of discharge home 
(Douglas et al., 2005). Furthermore, there 
was a lack of correlation between stroke 
units and decreased in-hospital mortality, 
a conclusion seemingly at odds with previ-
ous reports that clearly demonstrated that 
without any increase in protocol viola-
tions or complications. The number of 
admissions to stroke units was likewise 
higher in designated facilities, which is 
significant given the lower mortality and 
better functional recovery associated with 
these specialized units (Gropen et al., 
2006).
Similar results were reported in 
European stroke systems. Meretoja et al. 
(2010), looked at effectiveness of all pri-
mary and CSCs in Finland that fulfill 
standardized BAC criteria by reviewing 
data from all patients with ischemic stroke 
from 1999 to 2006. These observations 
concluded that care in stroke centers was 
associated with lower 1-year case-fatality 
and reduced post-acute institutional care 
compared with general hospitals. The 
number-needed-to-treat to prevent one 
death or institutional care at 1 year was 
29 for CSC equivalent hospitals and 40 
for PSC equivalent hospitals compared to 
general hospitals. Patients treated in stroke 
centers had lower mortality during the 
3. Surgical and endovascular capabilities, 
including clipping and coiling of intracra-
nial aneurysms, carotid endarterectomy, 
and intra-arterial thrombolytic therapy.
4. Other specific infrastructure and pro-
grammatic elements such as an inten-
sive care unit and a stroke registry.
The impact of PSC designation on 
improving stroke care has been positively 
described in multiple reports. Gropen 
et al. (2006) compared the quality of care 
provided by PSC in acute stroke settings 
in New York state designated stroke cent-
ers vs. non-designated hospitals. In this 
study, the authors examined the outcome 
of stroke systems that linked early stroke 
recognition and transport to stroke cent-
ers to delivery of care. They concluded 
that ischemic stroke patients evaluated in 
a designated facility were seen by physi-
cians twice as quickly once they reached 
the hospital, head CTs were performed 
twice as rapidly for appropriate tPA can-
didates, and use of tPA more than doubled 
Table 1 | Major elements of a primary stroke center or PSC (Alberts et al., 2000).
Acute stroke teams
Written care protocol
Emergency medical services
Emergency department
Stroke unit (if patients are admitted)
Neurosurgical services
Commitment and support of a medical organization including a stroke center director
Neuroimaging services
Laboratory services
Outcome and quality improvement activities
Continuing medical education
Table 2 | JCAHO standardize stroke performance measures (http://www.jointcommission.org/
AboutUs/Fact_Sheets/psc_certification.htm).
Deep vein thrombosis prophylaxis
Discharged on antithrombotic therapy
Anticoagulation therapy for atrial fibrillation
Thrombolytic therapy administered to eligible patients
Antithrombotic therapy by end of hospital day 2
Discharged on lipid lowering medication if warranted (LDL > 100, not measured, or on medication prior 
to admission)
Dysphagia screening*
Stroke education
Smoking cessation/advice/counseling*
Assessed for rehabilitation
*Retired effective January 2010.
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sion of acute care to other types and facets 
of complex stroke care are ongoing chal-
lenges that must be addressed if the stroke 
center concept is to prove workable and 
more effective on a nationwide scale.
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accumulates. At present, patients who are 
ineligible for intravenous tPA who might 
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taken, via bypass mechanisms even if avail-
able, to the nearest IA capable center but 
rather, at best, only to the nearest PSC.
Finally, while the PSC process has clearly 
improved the level of care delivered to 
stroke patients, adherence to recommended 
national quality guidelines was also associ-
ated with improvements in a number of the 
composite measures when an organized sys-
tem based on the Get-with-the Guidelines 
database was implemented. Improvements 
were seen in all seven individual measures 
quality improvement measures (Schwamm 
et al., 2009). The documentation require-
ments, however, are often burdensome, and 
a “one-size-fit all” template approach may 
result in inappropriate patient evaluations. 
Thus, while the PSC concept has improved 
the overall quality of care, the lack of organ-
ized stroke systems, with appropriate pre-
hospital triage, lack of diversion of patients 
to appropriate levels of care, shortage of 
stroke expertise, and problems with exten-
stroke unit care is  associated with reduced 
mortality and better functional outcome 
(Stroke Unit Trialists’ Collaboration, 2007).
One important requirement for estab-
lishment of a PSC is community educa-
tion and pre-hospital screening of stroke 
patients. In 2005, the Behavioral Risk 
Factor Surveillance System (BRFSS) 
reported that out of those screened, only 
38.1% were aware of five stroke warning 
symptoms or signs and would first call 
“911” if they thought someone is hav-
ing a stroke or a heart attack [Centers for 
Disease Control and Prevention (CDC), 
2008]. About 41.3% of these respondents 
were white, 29.5% African-Americans, 
and 26.8% were Hispanic [Centers for 
Disease Control and Prevention (CDC), 
2008]. Similarly, other studies including 
random telephonic surveys concluded 
that there is insufficient awareness in com-
munity about risk factors, warning signs, 
and prevention strategies of stroke. Wall 
et al. (2008) with the Massachusetts Heart 
Disease and Stroke Prevention Program 
report that measures such as Stroke Heroes 
Act FAST media and public awareness 
campaign is extremely important because 
stroke outcome may not improved unless 
people recognize the warning signs of 
stroke and activate the system by calling 
911, regardless of attempts to improve 
EMS and hospital emergency department 
systems.
Education for health care providers is 
also lacking. For example, a survey of 308 
internal medicine residency programs 
showed that only 46% required rotation 
in neurology; in contrast 97% required the 
study of cardiology (Maron et al., 2005). 
The report concluded that under-repre-
sentation of neurology training amongst 
internists may lead to under-recognition 
of stroke signs and symptoms and may 
effect stroke outcome. There is also ongoing 
resistance to thrombolytic therapy among a 
sub-segment of emergency room physicians 
which may partly reflect lack of education 
but also lack of organized systems of care. In 
a 2005 report, 40% of emergency physicians 
were unlikely to give tPA to stroke patients 
because of fear of complications (Brown 
et al., 2005). With the development of stroke 
systems of care, however, emergency physi-
cians have gradually become more accepting 
of stroke thrombolysis within the context of 
formal guidelines and PSC systems.
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